Intranasal Dexmedetomidine in Children Undergoing Adenotonsillectomy Suffering From Mild Upper Respiratory Tract Infection

• Status: Not yet recruiting
• Trial end date: 2023-05-15
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to detect the efficacy of intranasal dexmedetomidine as a premedication to general anesthesia in pediatric patients with respiratory comorbidities undergoing adenotonsillectomy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Tanta University
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

1. Children with recent mild URI or asthma.

2. aged from 3 to 10 years

3. ASA Physical Status II,

4. undergoing adenotonsillectomy

Exclusion Criteria:

1. Parental refusal of participation

2. Evidence of moderate to severe upper respiratory tract infection at time of presentation on the day of surgery

3. Lower respiratory tract infection

4. Congenital heart diseases

5. Known hypersensitivity to specific anesthetic agent

6. Liver or renal disease